Cherney; Robert J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cherney; Robert J..The latest application filed is for "heterocyclic sulfones as ror gamma modulators".

Company Profile

3.34.28

Cherney; Robert J. - Newtown PA
Cherney; Robert J. - Newton PA
Cherney; Robert J - Newtown PA
Cherney; Robert J. - Princeton NJ
Cherney; Robert J. - Newark DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic sulfones as ROR gamma modulators Grant 10,934,286 - Liu , et al. March 2, 2	2021-03-02
Tricyclic sulfones as ROR.gamma. modulators Grant 10,711,020 - Duan , et al.	2020-07-14
Heterocyclic Sulfones As Ror Gamma Modulators App 20190300523 - LIU; Qingjie ; et al.	2019-10-03
Tricyclic Sulfones As Ror Gamma Modulators App 20190241588 - DUAN; Jingwu ; et al.	2019-08-08
Tricyclic sulfones as ROR.gamma. modulators Grant 10,273,259 - Duan , et al.	2019-04-30
Bicyclic heteroaryl amine compounds Grant 10,214,537 - Bhide , et al. Feb	2019-02-26
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors Grant 10,023,576 - Bhide , et al. July 17, 2	2018-07-17
Tricyclic Sulfones As Ror Gamma Modulators App 20180002358 - Duan; Jingwu ; et al.	2018-01-04
Heteroaryl Substituted Pyrrolotriazine Amine Compounds As Pi3k Inhibitors App 20170355698 - Bhide; Rajeev S. ; et al.	2017-12-14
Bicyclic Heteroaryl Amine Compounds App 20170355707 - Bhide; Rajeev S. ; et al.	2017-12-14
Tricyclic sulfones as ROR.gamma. modulators Grant 9,815,859 - Duan , et al. November 14, 2	2017-11-14
TRICYCLIC SULFONES AS RORy MODULATORS App 20160326195 - Duan; Jingwu ; et al.	2016-11-10
Tricyclic heterocyclic compounds Grant 9,216,972 - Dhar , et al. December 22, 2	2015-12-22
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,- 3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes Grant 8,906,920 - Carter , et al. December 9, 2	2014-12-09
Mandelamide heterocyclic compounds Grant 8,835,470 - Cherney , et al. September 16, 2	2014-09-16
N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,- 3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, A Dual Modulator Of Chemokine Receptor Activity, Crystalline Forms And Processes App 20140088109 - Carter; Percy H. ; et al.	2014-03-27
Piperidinyl compound as a modulator of chemokine receptor activity Grant 8,642,622 - Cherney , et al. February 4, 2	2014-02-04
Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases Grant 8,629,282 - Cherney , et al. January 14, 2	2014-01-14
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,- 3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes Grant 8,618,101 - Carter , et al. December 31, 2	2013-12-31
Heterocyclic Compounds As S1p1 Agonists For The Treatment Of Autoimmune And Vascular Diseases App 20130237566 - Cherney; Robert J. ; et al.	2013-09-12
N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,- 3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, A Dual Modulator Of Chemokine Receptor Activity, Crystalline Forms And Processes App 20130158039 - Carter; Percy H. ; et al.	2013-06-20
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,- 3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes Grant 8,383,812 - Carter , et al. February 26, 2	2013-02-26
Mandelamide Heterocyclic Compounds App 20130045964 - Cherney; Robert J. ; et al.	2013-02-21
Piperidinyl Compound As A Modulator Of Chemokine Receptor Activity App 20120149733 - Cherney; Robert J. ; et al.	2012-06-14
N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,- 3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, A Dual Modulator Of Chemokine Receptor Activity, Crystalline Forms And Processes App 20110086857 - Carter; Percy H. ; et al.	2011-04-14
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,829,571 - Carter , et al. November 9, 2	2010-11-09
Cyclic derivatives as modulators of chemokine receptors activity Grant 7,776,884 - Cherney August 17, 2	2010-08-17
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,696,205 - Cherney April 13, 2	2010-04-13
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,687,508 - Carter , et al. March 30, 2	2010-03-30
Modulators of chemokine receptor activity, crystalline forms and process Grant 7,671,062 - Yang , et al. March 2, 2	2010-03-02
Cyclic Derivatives As Modulators Of Chemokine Receptor Activity App 20090124668 - Carter; Percy H. ; et al.	2009-05-14
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,482,335 - Carter , et al. January 27, 2	2009-01-27
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity Grant 7,378,409 - Carter , et al. May 27, 2	2008-05-27
Cyclic Derivatives As Modulators Of Chemokine Receptor Activity App 20080114052 - Cherney; Robert J. ; et al.	2008-05-15
Cyclic Derivatives As Modulators Of Chemokine Receptor Activity App 20080108678 - Cherney; Robert J.	2008-05-08
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,338,947 - Cherney , et al. March 4, 2	2008-03-04
Modulators Of Chemokine Receptor Activity Crystalline Forms And Process App 20080027083 - Yang; Michael G. ; et al.	2008-01-31
Cyclic Derivatives As Modulators Of Chemokine Receptor Activity App 20080027080 - Carter; Percy H. ; et al.	2008-01-31
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,291,615 - Cherney November 6, 2	2007-11-06
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,183,270 - Cherney , et al. February 27, 2	2007-02-27
Cyclic derivatives as modulators of chemokine receptor activity App 20070032541 - Cherney; Robert J. ; et al.	2007-02-08
Cyclic derivatives as modulators of chemokine receptor activity App 20070032526 - Carter; Peroy H. ; et al.	2007-02-08
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,163,937 - Carter , et al. January 16, 2	2007-01-16
Cyclic derivatives as modulators of chemokine receptor activity Grant 7,087,604 - Cherney August 8, 2	2006-08-08
Cyclic derivatives as modulators of chemokine receptors activity App 20060135503 - Cherney; Robert J.	2006-06-22
Cyclic sulfonyl compounds as inhibitors of metalloproteases Grant 6,927,216 - Cherney , et al. August 9, 2	2005-08-09
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity App 20050054626 - Carter, Percy H. ; et al.	2005-03-10
Cyclic derivatives as modulators of chemokine receptor activity App 20050054627 - Carter, Percy H. ; et al.	2005-03-10
Cyclic derivatives as modulators of chemokine receptor activity App 20040235836 - Cherney, Robert J.	2004-11-25
Cyclic derivatives as modulators of chemokine receptor activity App 20040186140 - Cherney, Robert J. ; et al.	2004-09-23
Cyclic derivatives as modulators of chemokine receptor activity App 20030216434 - Cherney, Robert J.	2003-11-20
Cyclic sulfonyl compounds as inhibitors of metalloproteases App 20020086853 - Cherney, Robert J. ; et al.	2002-07-04
Polycyclic and heterocyclic chromophores for bis-imide tumoricidals Grant 5,585,382 - Patten , et al. December 17, 1	1996-12-17
Polycyclic and heterocyclic chromophores for bis-imide tumoricidals Grant 5,416,089 - Patten , et al. May 16, 1	1995-05-16
Unsymmetrical mono-3-nitro bis-naphthalimides as anticancer agents Grant 5,376,664 - Kaltenbach, III , et al. December 27, 1	1994-12-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.